Underutilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change?
- PMID: 35385797
- DOI: 10.1016/j.jacc.2022.03.351
Underutilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change?
Keywords: electronic health record; guideline-directed medical therapy; heart failure with reduced ejection fraction; implementation; randomized controlled trial.
Conflict of interest statement
Funding Support and Author Disclosures Dr Van Spall has received funding from the Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada. Dr Fonarow has received consulting fees from Abbott, Amgen, AstraZeneca, Bayer, Cytokinetics, Edwards, Janssen, Medtronic, Merck, and Novartis. Dr Mamas has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.J Am Coll Cardiol. 2022 Jun 7;79(22):2203-2213. doi: 10.1016/j.jacc.2022.03.338. Epub 2022 Apr 3. J Am Coll Cardiol. 2022. PMID: 35385798 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
